ct-044
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2019 (NCT04175743)
Timeline
Indications
Mechanism of action
- Unspecified targetAntioxidant
Antioxidant
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05008835 | Phase 2 | Jul 20, 2021 | Acadia Pharmaceuticals |
| NCT04855240 | Phase 2 | Mar 29, 2021 | Acadia Pharmaceuticals |
| NCT04252833 | Phase 1 | Feb 29, 2020 | CerSci Therapeutics, Lotus Clinical Research |
| NCT04175743 | Phase 1 | Dec 31, 2019 | CerSci Therapeutics, Lotus Clinical Research |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals | For profit | 2 | 2 | 1 | 2021 |
| CerSci Therapeutics | For profit | 2 | 0 | 1 | 2019 |
| Lotus Clinical Research | For profit | 2 | 2 | 1 | 2019 |
3 organizations
Page 1 / 1